VIVIMEDLAB

VIVIMED LABS

Small Cap BSE: 532660 NSE: VIVIMEDLAB
₹10.00
-0.1 (-0.99%)
As on 30 September, 2022 | 02:54

Vivimed Labs Share Price

Vivimed Labs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in VIVIMED LABS

Start SIP

Vivimed Labs Share Returns

  • Over 1 Month 1.52%
  • Over 3 Month -0.99%
  • Over 6 Month -33.99%
  • Over 1 Year -50.86%

Vivimed Labs Key Statistics

P/E Ratio -0.9
PEG Ratio -0.1
Market Cap Cr 83
Price to Book Ratio 0.2
EPS -8.2
Dividend 0
Relative Strength Index 44.46
Money Flow Index 47.32
MACD Signal 0.07
Average True Range 0.5

Vivimed Labs Investment Rating

  • Master Rating:
  • Vivimed Labs has an operating revenue of Rs. 222.13 Cr. on a trailing 12-month basis. An annual revenue de-growth of -73% needs improvement, Pre-tax margin of -27% needs improvement, ROE of -18% is poor and needs improvement. The company has a reasonable debt to equity of 17%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vivimed Labs Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 475352516235
Operating Expenses Qtr Cr 565559625155
Operating Profit Qtr Cr -9-2-7-1111-20
Depreciation Qtr Cr 454444
Interest Qtr Cr 91012999
Tax Qtr Cr 030000
Net Profit Qtr Cr -22-19-24-23-2-31

Vivimed Labs Technicals

EMA & SMA

Current Price
10.
-0.1 (-0.99%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 10.34
  • 50 Day
  • 10.51
  • 100 Day
  • 11.7
  • 200 Day
  • 14.93
  • 20 Day
  • 10.39
  • 50 Day
  • 10.28
  • 100 Day
  • 11.07
  • 200 Day
  • 14.93

Vivimed Labs Resistance and Support

PIVOT
₹10.29
Resistance
First Resistance 10.57
Second Resistance 11.04
Third Resistance 11.32
RSI 44.46
MFI 47.32
MACD Single Line 0.08
Support
First Resistance 9.82
Second Resistance 9.54
Third Resistance 9.07

Vivimed Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 74,142 5,639,241 76.06
Week 230,508 13,028,323 56.52
1 Month 287,928 19,279,662 66.96
6 Month 289,400 18,434,781 63.7

Vivimed Labs Result Highlights

Vivimed Labs Synopsis

NSE-Medical-Diversified

Vivimed Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 210.05 Cr. and Equity Capital is Rs. 16.58 Cr. for the Year ended 31/03/2021. Vivimed Labs Ltd. is a Public Limited Listed company incorporated on 22/09/1988 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L02411KA1988PLC009465 and registration number is 009465.
Market Cap 83
Sales 203
Shares in Float 6.55
No of funds 4
Yield
Book Value 0.18
U/D Vol ratio 0.8
LTDebt / Equity 13
Alpha -0.22
Beta 0.97

Vivimed Labs

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 20.96%21.98%28.57%
Foreign Portfolio Investors 1.64%1.64%1.64%
Individual Investors 57.38%53.46%48.82%
Others 20.02%22.92%20.97%

Vivimed Labs Management

Name Designation
Prof. Bhagvanth Rao Mamidpalli Chairman & Ind.Director
Mr. Santosh Varalwar Managing Director
Dr. Manohar Rao Varalwar Whole Time Director
Mr. Sandeep Varalwar Whole Time Director
Mr. Subhash Varalwar Non Executive Director
Mrs. Umanath Varahabhotla Independent Director
Dr. Jamalapuram Harigopal Independent Director

Vivimed Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vivimed Labs Corporate Action

Date Purpose Remarks
2022-08-12 Quarterly Results
2022-06-03 Audited Results (Revised) per share(20%)Dividend
2022-02-14 Quarterly Results
2021-11-13 Quarterly Results
2021-09-06 Preferential issue of shares

Vivimed Labs FAQs

What is Share Price of Vivimed Labs ?

Vivimed Labs share price is ₹10 As on 30 September, 2022 | 02:40

What is the Market Cap of Vivimed Labs ?

The Market Cap of Vivimed Labs is ₹82.9 Cr As on 30 September, 2022 | 02:40

What is the P/E ratio of Vivimed Labs ?

The P/E ratio of Vivimed Labs is -0.9 As on 30 September, 2022 | 02:40

What is the PB ratio of Vivimed Labs ?

The PB ratio of Vivimed Labs is 0.2 As on 30 September, 2022 | 02:40

Q1FY23